Scott Andrew Ferguson

Title: Scott Andrew Ferguson: Innovator in Antibacterial Compounds

Introduction

Scott Andrew Ferguson is a notable inventor based in Dunedin, New Zealand. He has made significant contributions to the field of antibacterial agents through his innovative research and development. His work focuses on novel compounds that have the potential to combat bacterial infections effectively.

Latest Patents

Ferguson's most recent patent involves quinoline sulfonamide compounds and their use as antibacterial agents. This invention provides novel quinoline sulfonamide compounds of Formula I, which are designed for the treatment or prevention of bacterial infections caused by both Gram-positive and Gram-negative bacteria. The patent specifically addresses infections caused by bacteria from the Enterobactericeae, Staphylococcaceae, or Streptococcaceae families. The compounds can be formulated into pharmaceutical or veterinary compositions, particularly for use in animal husbandry. Notably, these compositions can be administered as a spray directly to the udder of bovine animals, such as cows, to target mastitis-causing bacteria.

Career Highlights

Scott Andrew Ferguson is associated with Otago Innovation Limited, where he continues to advance his research in antibacterial compounds. His work has led to the development of a patent that holds promise for improving animal health and welfare in the agricultural sector.

Collaborations

Ferguson has collaborated with esteemed colleagues, including Margaret Anne Brimble and Greg Murray Cook. These partnerships have contributed to the depth and breadth of his research, enhancing the impact of his innovations in the field.

Conclusion

Scott Andrew Ferguson is a dedicated inventor whose work in antibacterial compounds is paving the way for new treatments in both human and veterinary medicine. His innovative approach and collaboration with other experts highlight the importance of research in combating bacterial infections.